MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing

IF 2.6 3区医学 Q3 ONCOLOGY

Seminars in Radiation Oncology Pub Date : 2023-12-15 DOI:10.1016/j.semradonc.2023.10.001

Rosalyne L Westley , Luca F Valle MD , Alison C Tree , Amar U. Kishan

引用次数: 0

Abstract

The advent of MRI guided radiotherapy (MRIgRT) offers enormous promise in the treatment of prostate cancer. The MR-linac offers men the opportunity to receive daily MR imaging to guide and influence their radiotherapy treatment. This review focuses on the advantages that MRIgRT potentially offers as well as any potential disadvantages to MRIgRT that may have been recognized thus far. Ongoing clinical trials evaluating this novel treatment platform for the treatment of prostate cancer are also discussed.

查看原文本刊更多论文

磁共振成像引导的前列腺癌放疗：眼见为实

磁共振成像引导放射治疗（MRIgRT）的出现为前列腺癌的治疗带来了巨大的希望。MR-linac为男性提供了每天接受磁共振成像的机会，以指导和影响他们的放疗。本综述将重点介绍 MRIgRT 可能带来的优势，以及迄今为止已认识到的 MRIgRT 的潜在缺点。此外，还讨论了正在进行的临床试验，这些临床试验评估了这种用于治疗前列腺癌的新型治疗平台。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in Radiation Oncology 医学-核医学

CiteScore

5.80

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.